Journal of the Formosan Medical Association (Mar 2012)

Recurrence of primary aldosteronism after percutaneous ethanol injection

  • Fan-Chi Chang,
  • Kao-Lang Liu,
  • Kuo-How Huang,
  • Vin-Cent Wu,
  • Yen-Hung Lin,
  • Yung-Ming Chen,
  • Kwan-Dun Wu,
  • TAIPAI Study Group

DOI
https://doi.org/10.1016/j.jfma.2012.01.009
Journal volume & issue
Vol. 111, no. 3
pp. 176 – 178

Abstract

Read online

Adrenalectomy is the definite treatment for aldosterone-producing adenoma (APA). Percutaneous ethanol or acetic acid injection with computed tomography (CT) guidance has been described as a safe, noninvasive, and effective alternative treatment modality in patients with high surgical risk. We report on a man who was 49 years of age and presented with treatment-resistant hypertension and was later diagnosed with APA. CT-guided percutaneous ethanol injection (PEI) was performed for this high surgical risk patient. He had aldosteronism recurrence 4 years after the ethanol injection, so a second PEI was performed. The tumor size was reduced and his blood pressure was normalized. Therefore, we suggest that clinicians should closely check aldosterone to renin ration and potassium level if percutaneous chemical ablation is considered in functioning adrenal adenomas.

Keywords